[New oral anticoagulants: from theory to practice].

@article{Moerloose2013NewOA,
  title={[New oral anticoagulants: from theory to practice].},
  author={Philippe de Moerloose and Alessandro Casini and Françoise Boehlen and Pierr Fontana},
  journal={Revue medicale suisse},
  year={2013},
  volume={9 369},
  pages={104-7}
}
Physicians are confronted with many new antithrombotic drugs, either antiplatelet agents or new oral anticoagulants (NOAC). Targets of NOAC are specific (either anti-IIa or antiXa) and clinical studies have shown that NOAC are as efficacious and as safe as "old" anticoagulants (heparin, low molecular weight heparin, vitamin K antagonists); moreover they… CONTINUE READING